Following a thorough review of the company's portfolio and long-term priorities conducted by Benchmark Genetics since it became an independent entity within Novo Holdings' investment portfolio in ...

NEW DELHI: In a big boost for the Navy and Indian Coast Guard, the defence ministry on Tuesday signed contracts worth Rs 5,083 crore for the acquisition of six Advanced Light Helicopters (ALH) Mk-III ...

https://www.thehindubusinessline.com/news/mod-inks-5083-cr-worth-acquisition-of-6-advanced-light-helicopters-mk-ii-for-coast-guards/article70699226.ece Copy As the ...

Leads Genetics, a subsidiary of BL Agro Group, has opened its integrated R&D centre for Indigenous Cattle Genetics & Genomics at BL Kamdhenu Farms and Leads Genetics Headquarters in Bareilly. The ...

Shares of Rayonier Advanced Materials rose after the company appointed Scott Sutton, former chief executive of Olin Corp., as its new CEO. The stock jumped 19% to $6.98. It is down 14% over the past ...

Its founders call it a Google search or ChatGPT for DNA. In essence, users can ask their genetics direct questions. But instead of receiving broad, sometimes unnecessarily disconcerting information ...

Scientists identified two types of brain cells, neurons and microglia, that are altered in people with depression. Through genomic mapping of post-mortem brain tissue, they found major differences in ...

Prostate cancer advancements highlight genetic mutations' impact on therapy and family health, emphasizing early treatment strategies for better outcomes. In recognition of September as Prostate ...

While the prospect The Elder Scrolls IV: Oblivion Remastered turning out to be a real thing had folks wondering what that might mean for Oblivion remake mod Skyblivion's release, Bethesda were quick ...

Development and validation of a novel circulating tumor cell response stratification criteria for metastatic castration-resistant prostate cancer clinical trials. This is an ASCO Meeting Abstract from ...

- FDA RMAT designation recognizes encouraging early data from Opus’ Phase 1/2 trial in patients with LCA5, an ultra-rare inherited retinal disease RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE ...